Advertisement
Neurocrine Biosciences, Inc.

Why Is Neurocrine Biosciences, Inc. (NBIX) Stock Down Today?

Live update on NBIX's stock movement with key data on price change, volume, technical indicators, sector trends, and analyst sentiment.

NBIXNASDAQ
HealthcareBiotechnology
$168.52
$4.34(2.64%)
U.S. Market opens in 44h 30m
Advertisement

NBIX is Up +2.64% today

You might want to check out Why is NBIX Up Today?

Neurocrine Biosciences, Inc. (NBIX)

Volume (Unusual)
1.94M
61.00%
Open / Previous Close
$163.59 / $164.18
Day Range (Low / High)
$163.12 - $169.56

Summary

Neurocrine Biosciences, Inc. (NBIX) is trading up +2.64% at $168.52, reflecting a positive shift in investor sentiment today. The stock opened at $163.59 and has moved between $163.12 and $169.56 so far.

Trading volume is 1944117, which is 61% above its average, and the price action suggests buying interest.

Technically, NBIX is trading above its 50-day moving average of $150.26 and above its 200-day moving average of $141.73, indicating short-term and long-term strength.

Meyka's AI assigns NBIX a grade of B (Overall moderate), reflecting its assessment of fundamentals and sentiment. Forecast models project potential returns of +0.08% in 1 month ($168.65), -7.19% in 1 year ($156.41), and +20.48% in 5 years ($203.03).

View the full chart, check forecasting details, or see the AI grade breakdown to explore what's driving this stock's movement.
Stay informed and make better investment decisions.

NBIX Technical Signals

Trading over 50-day moving average ($150.26)

Trading over 200-day moving average ($141.73)

Analyst Recommendations data is not available for NBIXAnalyst Recommendations details for NBIX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Price Forecast

1 Month

$168.65

1 Year

$156.41

3 Years

$179.62

5 Years

$203.03

B+
Good70.00

Is this change significant?

5-Day:+4.56%

1-Month:+8.21%

3-Month:+27.26%

What's next?

Next earnings date: 7/30/2025

Frequently Asked Questions